RELATIVE ROLES OF DECAY-ACCELERATING FACTOR, MEMBRANE COFACTOR PROTEIN, AND CD59 IN THE PROTECTION OF HUMAN ENDOTHELIAL-CELLS AGAINST COMPLEMENT-MEDIATED LYSIS

被引:78
作者
BROOIMANS, RA
VANWIERINGEN, PAM
VANES, LA
DAHA, MR
机构
[1] Department of Nephrology, University Hospital, Leiden
关键词
D O I
10.1002/eji.1830221216
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human umbilical vein endothelial cells (HUVEC) were found by Western blot analysis to express three membrane-bound C regulatory proteins, decay-accelerating factor (DAF). membrane cofactor protein (MCP) and CD59. DAF was detected on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a 70-kDa molecule under nonreducing conditions in 2 % deoxycholate extracts of HUVEC, MCP as a 63-kDa protein and CD59 as a 20-kDa molecule. Northern blot analysis revealed the presence of two species of mRNA expressed in HUVFC, which hybridized to a cDNA probe specific for DAF, with sizes of about 2.0 kb and 2.7 kb. MCP mRNA was detected at 4.2 kb and a CD59 cDNA probe hybridized with three mRNA species with sizes of about 800, 1400 and 2(XX) bp. DAF and CD59 were released from the surface of HUVEC by phosphatidylinositol-phospholipase C. demonstrating that both are attached to the cell membrane by means of a glycolipid anchor.The relative contribution of DAF, MCP and CD59 in regulating the sensitivity to lysis of HUVEC by autologous complement was determined by incubation of sensitized endothelial cells with F(ab')2 fragments of polyclonal antibodies raised against these proteins. The susceptibility of sensitized cells to lysis by homologous complement was markedly increased in the presence of F(ab')2 anti-CD59 and to a lesser, but significant. extent in the presence of F(ab')2 anti-DAF. F(ab')2 anti-MCP did not significantly alter the susceptibility of HUVEC to complement-mediated lysis.
引用
收藏
页码:3135 / 3140
页数:6
相关论文
共 39 条
[1]   DECAY-ACCELERATING FACTOR IS PRESENT ON CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS [J].
ASCH, AS ;
KINOSHITA, T ;
JAFFE, EA ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (01) :221-226
[2]  
BALLARD L, 1987, J IMMUNOL, V138, P3850
[3]  
BROOIMANS RA, 1989, J IMMUNOL, V142, P2024
[4]  
BROOIMANS RA, 1992, J IMMUNOL, V22, P791
[5]   CLONING OF DECAY-ACCELERATING FACTOR SUGGESTS NOVEL USE OF SPLICING TO GENERATE 2 PROTEINS [J].
CARAS, IW ;
DAVITZ, MA ;
RHEE, L ;
WEDDELL, G ;
MARTIN, DW ;
NUSSENZWEIG, V .
NATURE, 1987, 325 (6104) :545-549
[6]  
CHO SW, 1991, CLIN EXP IMMUNOL, V83, P257
[7]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]   CD59, AN LY-6-LIKE PROTEIN EXPRESSED IN HUMAN LYMPHOID-CELLS, REGULATES THE ACTION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX ON HOMOLOGOUS CELLS [J].
DAVIES, A ;
SIMMONS, DL ;
HALE, G ;
HARRISON, RA ;
TIGHE, H ;
LACHMANN, PJ ;
WALDMANN, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :637-654
[9]   RELEASE OF DECAY-ACCELERATING FACTOR (DAF) FROM THE CELL-MEMBRANE BY PHOSPHATIDYLINOSITOL-SPECIFIC PHOSPHOLIPASE-C (PIPLC) - SELECTIVE MODIFICATION OF A COMPLEMENT REGULATORY PROTEIN [J].
DAVITZ, MA ;
LOW, MG ;
NUSSENZWEIG, V .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) :1150-1161
[10]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13